HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeremie Vitte Selected Research

Jeremie Vitte Research Topics

Disease

8Neoplasms (Cancer)
11/2023 - 07/2013
5Neurilemmoma (Schwannoma)
02/2024 - 07/2013
3Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2019 - 07/2013
3Carcinogenesis
11/2016 - 07/2013
2Acoustic Neuroma (Acoustic Neurinoma)
02/2024 - 04/2014
2Schwannomatosis
11/2023 - 03/2013
2Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2023 - 01/2018
1Neurofibromatoses (Neurofibromatosis)
11/2023
1Rare Diseases (Rare Disease)
11/2023
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Inflammation (Inflammations)
11/2016
1Hepatomegaly
11/2016
1Meningioma (Meningiomas)
07/2013

Drug/Important Bio-Agent (IBA)

4Neurofibromin 2 (Merlin)IBA
01/2023 - 04/2014
3Proteins (Proteins, Gene)FDA Link
11/2023 - 07/2013
2Mechanistic Target of Rapamycin Complex 1IBA
02/2024 - 04/2014
2Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2023
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 07/2013
1EverolimusFDA Link
02/2024
1LigandsIBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1trametinibIBA
01/2019
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2019
1Neurofibromin 1 (Neurofibromin)IBA
01/2018
1CyclinsIBA
11/2016
1CytokinesIBA
11/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2016
1Sirolimus (Rapamycin)FDA Link
04/2014
1TOR Serine-Threonine KinasesIBA
04/2014
1pochoxime AIBA
07/2013

Therapy/Procedure

3Therapeutics
11/2023 - 07/2013
1Drug Therapy (Chemotherapy)
03/2013